Anti-aggregatory and fibrinolytic effects of time-released garlic powder tablets

The double-blinded placebo-controlled randomized crossover study was performed in 29 atherosclerotic men (35 to 70 years old) suffering from cerebral atherosclerosis and chronic cerebrovascular insufficiency to elucidate the effect of time-released garlic powder tablets Allicor on platelet aggregation and serum fibrinolytic activity. It has been demonstrated that Allicor 14-days treatment significantly inhibited ADP-induced platelet aggregation by 25.4% (p<0.05) and increased plasma fibrinolytic activity by 22.4% (p<0.05). Additionally, the trend to the decrease in plasma fibrinogen level was observed. Evidence obtained from this study indicates that garlic has potential in the prevention and control of cardiovascular disorders and is beneficial when taken as a dietary supplement. We conclude that Allicor may be beneficial in protecting against cardiovascular disease as a result of inhibiting platelet aggregation and normalizing plasma fibrinolytic activity.

[1]  R. Verhaeghe.  Prophylactic Antiplatelet Therapy in Peripheral Arterial Disease , 2012, Drugs.

[2]  J. Easton.  Antiplatelet Therapy in the Prevention of Stroke , 2012, Drugs.

[3]  A. Makheja,et al.  Antiplatelet constituents of garlic and onion , 1990, Agents and Actions.

[4]  E. Jung,et al.  Effects of garlic coated tablets in peripheral arterial occlusive disease , 1993, The clinical investigator.

[5]  D. Leys,et al.  Atherothrombosis: A Major Health Burden , 2001, Cerebrovascular Diseases.

[6]  C. Mulrow,et al.  Garlic shows promise for improving some cardiovascular risk factors. , 2001, Archives of internal medicine.

[7]  M. Steiner,et al.  Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions. , 2001, The Journal of nutrition.

[8]  K. Rahman,et al.  Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. , 2000, The Journal of nutrition.

[9]  W. Aronow.  Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease , 1999, Drugs & aging.

[10]  J. Michaelis,et al.  Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers. , 1999, Atherosclerosis.

[11]  T. Sudhop,et al.  Garlic preparations for prevention of atherosclerosis. , 1998, Current opinion in lipidology.

[12]  K. C. Srivastava,et al.  Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  K. C. Srivastava,et al.  Effect of garlic on platelet aggregation in humans: a study in healthy subjects and patients with coronary artery disease. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  T. Bordia,et al.  An evaluation of garlic and onion as antithrombotic agents. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.

[15]  M. Ali,.  Mechanism by which garlic (Allium sativum) inhibits cyclooxygenase activity. Effect of raw versus boiled garlic extract on the synthesis of prostanoids. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  D. Waters,et al.  Platelet aggregation, coronary artery disease progression and future coronary events. , 1994, The American journal of cardiology.

[17]  A. J. Valente,et al.  A modern view of atherogenesis. , 1993, The American journal of cardiology.

[18]  E. Jung,et al.  Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. , 1991, International journal of clinical pharmacology, therapy, and toxicology.

[19]  M. Ali,,et al.  Antithrombotic activity of garlic: its inhibition of the synthesis of thromboxane-B2 during infusion of arachidonic acid and collagen in rabbits. , 1990, Prostaglandins, leukotrienes, and essential fatty acids.

[20]  A. Eiber,et al.  Hypertension and hyperlipidaemia: garlic helps in mild cases. , 1990, British journal of clinical practice. Supplement.

[21]  F. Jung,et al.  Effects of garlic on blood fluidity and fibrinolytic activity: a randomised, placebo-controlled, double-blind study. , 1990, British journal of clinical practice. Supplement.

[22]  Z. Gabbasov,et al.  Platelet aggregation: the use of optical density fluctuations to study microaggregate formation in platelet suspension. , 1989, Thrombosis research.

[23]  J. Harenberg,et al.  Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. , 1988, Atherosclerosis.

[24]  S. Mohammad,et al.  Characterization of a potent inhibitor of platelet aggregation and release reaction isolated from allium sativum (garlic). , 1986, Thrombosis research.

[25]  M. Ali,,et al.  Selective suppression of platelet thromboxane formation with sparing of vascular prostacyclin synthesis by aqueous extract of garlic in rabbits. , 1986, Prostaglandins, leukotrienes, and medicine.

[26]  K. C. Srivastava.  Evidence for the mechanism by which garlic inhibits platelet aggregation. , 1986, Prostaglandins, leukotrienes, and medicine.

[27]  W. Schwartzkopff,et al.  Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. , 1986, Arzneimittel-Forschung.

[28]  A. Bordia.  Effect of garlic on blood lipids in patients with coronary heart disease. , 1981, The American journal of clinical nutrition.

[29]  A. Bordia,et al.  The effect of fried versus raw garlic on fibrinolytic activity in man. , 1981, Atherosclerosis.

[30]  P. Steele,et al.  Platelet Function Studies in Coronary Artery Disease , 1973, Circulation.

[31]  T. Astrup,et al.  Effects of preparations of heparin and heparitin sulfate on fibrinolysis. , 1966, Archives of biochemistry and biophysics.

[32]  E. Bidwell.  Fibrinolysins of human plasma; a comparison of fibrinolytic plasma from normal subjects and from cadaver blood with plasmin prepared by activation with chloroform. , 1953, The Biochemical journal.